Related Experiment Video

Updated: Jun 7, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Genome scale CRISPRi reveals both shared and strain-specific vulnerabilities in genetically diverse drug-resistant

XinYue Wang1,2, William J Jowsey1,2, Chen-Yi Cheung1

  • 1Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.

Nature Communications
|June 5, 2026
PubMed

Insights

Drug-resistant tuberculosis strains exhibit shared vulnerabilities in essential pathways, particularly tRNA synthetases. Functional genomics reveals new drug targets to combat resistant Mycobacterium tuberculosis.

Area of Science:

  • Microbiology
  • Genomics
  • Drug Discovery

Background:

  • Tuberculosis (TB) poses a significant global health challenge, exacerbated by increasing drug resistance in Mycobacterium tuberculosis.
  • Drug resistance mutations can induce collateral effects, creating new vulnerabilities in bacterial pathways.

Purpose of the Study:

  • To identify collateral effects associated with drug-resistant Mycobacterium tuberculosis genotypes using genome-scale CRISPR interference.
  • To pinpoint novel drug targets that are effective against drug-resistant strains.

Main Methods:

  • Genome-scale CRISPR interference screening was employed to systematically assess gene essentiality across different drug-resistant M. tuberculosis genotypes.
  • Analysis focused on identifying shared and genotype-specific vulnerabilities in functional pathways.

Main Results:

  • Drug resistance in M. tuberculosis leads to shared vulnerabilities in overlapping functional pathways.
  • Most drug-resistant strains showed increased sensitivity to knockdowns of tRNA synthetases, identifying them as potential drug targets.
  • A specific rifampicin-resistant mutant (RpoB(S450L)) exhibited heightened sensitivity to sulfur metabolism dysregulation, linked to transcriptional dynamics.
  • Clinical isolates showed lineage-specific mutations in sulfur metabolism genes, suggesting adaptation to mitigate collateral fitness costs.

Conclusions:

  • Functional genomics is a powerful approach for discovering drug targets effective against drug-resistant Mycobacterium tuberculosis.
  • tRNA synthetases represent promising targets for broad-spectrum anti-TB drug development.
  • Understanding collateral effects is crucial for developing strategies to overcome drug resistance in tuberculosis.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Evolution of Microbial Genome01:08

Evolution of Microbial Genome

Microbial genome evolution is a highly dynamic process shaped by continual gene gain and loss across species and strains. This genomic flexibility allows microorganisms to adapt rapidly to environmental pressures and interactions with other organisms. Central to understanding this diversity is the distinction between the core and pan genomes.The core genome comprises the genes shared by all sampled strains of a species, representing essential functions needed for fundamental cellular processes.